Nitro-tab

Nitro-tab Ketone Tablets

Nitro-tab-acetoacetic-acid-and-acetone-test

Key features

Urine results in 30 seconds
Serum and plasma results in 2 minutes
Whole blood result in 10 minutes
Room temperature storage for tablets
CLIA waived for urine testing

Inquire now

Ketone tablets

Nitro-tab ketone tablets are used for the semi-quantitative determination of ketones

(acetoacetic acid and acetone) in urine, serum, plasma and whole blood.

The test is CLIA waived for urine testing and CLIA moderately complex for serum, plasma

and whole blood.

Nitro-tab ketone tablets can be stored at room temperature. Control materials are

available to confirm positive and negative results.

Easy and convenient results

Place a tablet on a clean, dry, white paper and add one drop of specimen to the tablet.

Urine results are read after 30 seconds, serum and plasma after 2 minutes, and whole blood after 10 minutes. The test is positive if the tablet shows a purple color. A CLSI formatted procedure is available.

Measure acetoacetic acid and acetone in urine, serum, plasma and whole blood

Principle of the test

Acetoacetic acid or acetone in urine or blood will form a complex with nitroprusside in the presence of glycerine. A buffer provides the optimum pH for this reaction.

Please note: Any purple color indicates a positive reaction.

Nitro-tab-Ketone-Tablets

Specifications

Methodology	Contents	Storage	Reference No.
Nitro-tab Ketone Tablets	100 ct.	15 - 30^oC	4000-100
Ketone Urine Controls	1 x 5 mL – Positive 1 x 5 mL – Negative	2 - 8^oC	4020-005
Ketone Serum Controls	1 x 2 mL – Positive 1 x 2 mL – Negative	2 - 8^oC	4010-002

Downloads

Nitro-tab Product Sheet

Inquire now

* Not available in the EU

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

New R&D facility in Head Office

Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities

Medica 2019

Medica is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every professional's calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.

EKF to highlight Lucica® Glycated Albumin-L assay for diabetes patient monitoring at AACC 2019

EKF announces the availability of a liquid, enzymatic test for glycated albumin (GA) that was recently FDA cleared for sales in the U.S. GA, used for intermediate term monitoring of glycemic control in diabetes patients, will be showcased at the 2019 AACC.

EKF at InterLab - Algiers, Algeria 2019

The third edition of the exhibition will be held on 25-27 September 2019 at the Palais des Expositions, SAFEX, Algiers, Algeria.

EKF Quo-Test supports improved medical management of diabetic retinopathy patients